Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tetraphase Pharmaceuticals

2.20
0.0000
Volume:- -
Turnover:- -
Market Cap:15.98M
PE:-0.17
High:2.20
Open:2.20
Low:2.20
Close:2.20
Loading ...
Jul 29, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 29, 2020

Major Issues Report

8-K - Current report
Jul 28, 2020

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Jul 01, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 30, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 26, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 24, 2020

Major Issues Report

8-K - Current report
Jun 22, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 22, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 05, 2020

Major Issues Report

8-K - Current report
Jun 04, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
May 29, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
May 29, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
May 28, 2020

Major Issues Report

8-K - Current report
May 28, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
May 27, 2020

Business Combinations

425 - Prospectuses and communications, business combinations